Literature DB >> 11094645

FDA approves new protease inhibitor for HIV infection.

J L Miller.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11094645     DOI： 10.1093/ajhp/57.21.1942

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  2 in total

1.  Metabolism and disposition of the HIV-1 protease inhibitor lopinavir (ABT-378) given in combination with ritonavir in rats, dogs, and humans.

Authors:  Gondi N Kumar; Venkata K Jayanti; Marianne K Johnson; John Uchic; Samuel Thomas; Ronald D Lee; Brian A Grabowski; Hing L Sham; Dale J Kempf; Jon F Denissen; Kennan C Marsh; Eugene Sun; Stanley A Roberts
Journal:  Pharm Res       Date:  2004-09       Impact factor: 4.200

2.  Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor.

Authors:  Sheetal Agarwal; Dhananjay Pal; Ashim K Mitra
Journal:  Int J Pharm       Date:  2007-03-06       Impact factor: 5.875
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.